NANTES, FRANCE--(Marketwire - April 14, 2008) - VIVALIS (Euronext Paris: VLS) is a public biopharmaceutical company that provides innovative cell-based solutions for the industrial manufacture of viral vaccines and therapeutic proteins, and develop drugs for the prevention of viral diseases. VIVALIS will attend the Small cap event in Paris on April 21 and 22 in “Hotel Hilton, 18 avenue de Suffren”.
